Abstract
The treatment of short children without GH deficiency (GHD) poses a major question: whether or not short-term changes of GH-dependent parameters could predict the long-term growth response to GH treatment. For this purpose, scrum IGF-I and IGFBP-3 levels were studied in short prepubcrtal children without “classical” GHD as defined by a peak GH level above 20 mU/L in the arginine-insulin-tolerance test (5 girls, 33 boys, age 8.9±1.9 yr) receiving 0.1 IU rhGH per kg body weight daily. Height velocity (HV) was determined during a 1-yr pretreatment period and during the 1st (n=38) and 2nd (n=32) year of treatment. IGF-I and IGFBP-3 were measured by specific RIAs at start of therapy (index 0) and after 1 month (index 1m).
Results: HV (mean±SD) increased from 4.97±1.04 cm/yr to 7.60±0.99 and 6.42±1.24 cm/yr during the 1st and 2nd year resp. The 1 month increase of IGF-I levels was from 131±54 μg/l 199±90 μg/l and of IGFBP-3 from 2.84±0.68 mg/l to 3.57±0.90 mg/l. The correlation coefficients and p-values between IGF-parameters (IGF-I0, ΔIGF-I= IGF-I1m - IGF-I0 %IGF-1= IGF-I1m/IGF-I0. IGFBP-3 accordingly) and the increases of HV during the 1st (ΔHV1) and 2nd year (ΔHV2) are given below (rs(p):
Conclusions: 1) Low basal IGF-I and IGFBP-3 levels predict a good growth response during the 1st year, but not thereafter. 2) The predictive potential of the short-term increases of IGF-I and IGFBP-3 is belter for the 2nd year than Die 1st year. 3) IGFBP-3 is superior to IGF-I due to its negligible circadian fluctuations during GH therapy.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blum, W., Rosberg, S., Ranke, M. et al. THE SHORT-TERM INCREASES OF IGF-I AND IGFBP-3 DURING GH TREATMENT PREDICT THE LONG-TERM GROWTH RESPONSE IN SHORT CHILDREN. Pediatr Res 33 (Suppl 5), S48 (1993). https://doi.org/10.1203/00006450-199305001-00272
Issue Date:
DOI: https://doi.org/10.1203/00006450-199305001-00272